Search hospitals > Ontario > TORONTO
The Hospital for Sick Children
Claim this profileTORONTO, Ontario M5G 1X8
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Solid Tumors
Conducts research for Neuroblastoma
964 reported clinical trials
83 medical researchers
Summary
The Hospital for Sick Children is a medical facility located in TORONTO, Ontario. This center is recognized for care of Cancer, Brain Tumor, Adult T-Cell Leukemia/Lymphoma, Solid Tumors, Neuroblastoma and other specialties. The Hospital for Sick Children is involved with conducting 964 clinical trials across 1,309 conditions. There are 83 research doctors associated with this hospital, such as Daniel Morgenstern, MBChir, Eric Bouffet, MD, Vijay Ramaswamy, and Glenda Courtney-Martin, PhD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Brain Tumor
Global LeaderStage IV
NTRK positive
Stage II
Top PIs
Daniel Morgenstern, MBChirHospital for Sick Children3 years of reported clinical research
Studies Neuroblastoma
Studies Cancer
15 reported clinical trials
32 drugs studied
Eric Bouffet, MDThe Hospital for Sick Children (SickKids)1 year of reported clinical research
Studies Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
10 reported clinical trials
15 drugs studied
Vijay RamaswamyHospital for Sick Children6 years of reported clinical research
Studies Medulloblastoma
Studies Brain Cancer
7 reported clinical trials
14 drugs studied
Glenda Courtney-Martin, PhDThe Hospital For Sick Children1 year of reported clinical research
Studies Healthy Subjects
Studies Inflammatory Bowel Disease
5 reported clinical trials
4 drugs studied
Clinical Trials running at The Hospital for Sick Children
Crohn's Disease
Testicular cancer
Sickle Cell Disease
Neuroblastoma
Ulcerative Colitis
Testicular Carcinoma
Ovarian Carcinoma
Ovarian Tumors
Ovarian Choriocarcinoma
Acute Lymphoblastic Leukemia
Mirikizumab
for Ulcerative Colitis
This trial is testing a medication called mirikizumab to see if it can help children with ulcerative colitis or Crohn's disease by reducing inflammation in their digestive tracts.
Recruiting2 awards Phase 33 criteria
Mirikizumab
for Pediatric Crohn's Disease
Study participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to evaluate efficacy, safety, tolerability, and how well mirikizumab absorbs into the body of pediatric participants with Crohn's disease. Study periods for the intervention-specific appendix (ISA) will be as follows: * A 12-week induction period * A maintenance period from Week 12 to Week 52, and * A safety follow-up period up to 16 weeks. The study will last about 74 weeks and may include up to 19 visits.
Recruiting2 awards Phase 3
Guselkumab
for Pediatric Crohn's Disease
This trial tests guselkumab, an anti-inflammatory medication, on children with Crohn's Disease who initially responded well to it. The goal is to see if the benefits last over several months by reducing immune system activity. Guselkumab has shown effectiveness in treating moderate-to-severe psoriasis and psoriatic arthritis.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at The Hospital for Sick Children?
Where is The Hospital for Sick Children located?
Who should I call to ask about financial aid or insurance network?
What insurance does The Hospital for Sick Children accept?
What awards or recognition has The Hospital for Sick Children received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.